ABSTRACT PURPOSE: To assess axis alignment and stability of the Toric Implantable Collamer Lens (TICL; STAAR Surgical Co) over time.
METHODS:
Thirty-fi ve consecutive eyes of 19 patients received the TICL for treatment of myopic astigmatism. Manifest refraction spherical equivalent (MRSE) and manifest refractive cylinder were measured preoperatively and at 3 months postoperatively. The axis alignment of the TICL was measured using the internal OPD map obtained with the OPD-Scan II (NIDEK Co Ltd).
RESULTS:
Mean refractive cylinder was reduced from 2.80Ϯ1.45 diopters (D) preoperatively to 0.63Ϯ0.75 D at 3 months postoperatively; MRSE was Ϫ7.61Ϯ4.02 D preoperatively and Ϫ0.14Ϯ0.38 D at 3 months. Mean absolute value of the measured axis misalignment from baseline (day 1) to 1 month was 2.90Ϯ2.11º and from 1 month to 3 months was 4.6Ϯ11.2°. Mean absolute value of the measured changes in axis misalignment from baseline to 3 months was 2.68Ϯ2.11° (after excluding one eye that required repositioning due to TICL rotation). At 3 months postoperatively, 96.8% (30/31) eyes had р8° and 90.3% (28/31) had р5° of axis misalignment.
CONCLUSIONS:
The TICL showed minimal axis misalignment after implantation and remained stable 3 A stigmatism is a common refractive error with several modalities available for correction, such as spectacles and contact lenses. Although a safe method, optical correction is frequently not suitable for patients due to occupational hazards or for cosmetic reasons.
Corneal refractive surgery including LASIK, photorefractive keratectomy, and astigmatic keratotomy are relatively safe, widely used techniques but may be associated with corneal ectasia, low predictability, regression, and poor quality of vision. 1, 2 Toric phakic intraocular lens (IOL) implantation is an alternative when safety or predictability of corneal refractive surgery is a concern. Although several studies have demonstrated effective treatment of astigmatism using iris-fi xated toric phakic IOLs, [3] [4] [5] concerns exist regarding endothelial cell loss and surgically induced astigmatism by implantation of a rigid, polymethylmethacrylate (PMMA) lens through a 5.3-mm incision. 3, 6 A relative paucity of studies on misaligned Toric Implantable Collamer Lens (TICL; STAAR Surgical Co, Monrovia, Calif) exist in the literature. 7, 8 To our knowledge, only one study reported axis misalignment identifi ed by slit-lamp microscopy 2 and another study that assessed axis alignment after implantation. 9 The aim of our prospective study was to objectively measure the axis alignment of implanted TICLs and to study the rotational stability of the lens over time. The TICL is a posterior chamber phakic IOL designed to vault anteriorly, intended to have minimal contact with the crystalline lens, and is made from a new generation of IOL material termed "collamer," 10, 11 which is composed of hydrophilic porcine collagen (Ͻ0.1%) hydroxyethyl methacrylate (HEMA) copolymer into which an ultraviolet-absorbing chromophore is incorporated in the polymer chain.
PATIENTS AND METHODS
The study inclusion criteria were phakic patients with myopia and astigmatism ranging from 1.00 to 5.00 diopters (D), a stable refraction for the past 12 months as documented by previous records, no history of ocular surgery, glaucoma, ocular hypertension, keratoconus and/or any ophthalmic or non-ophthalmic condition that may preclude study completion, endothelial cell count Ͼ2300/mm 2 , and anterior chamber depth Ͼ2.75 mm measured with the IOLMaster (Carl Zeiss Meditec Inc, Dublin, Calif).
Ocular examination, including uncorrected visual acuity (UCVA), Snellen best spectacle-corrected visual acuity (BSCVA), manifest refraction, applanation tonometry, slit-lamp microscopy, dilated fundus examination, and noncontact specular microscopy (EM 3000; Tomey Corp, Nagoya, Japan), was performed in all eyes before surgery.
The TICL power and size were calculated using the software provided by the manufacturer and horizontal white-to-white was measured by Orbscan II (Bausch & Lomb, Salt Lake City, Utah). If a discrepancy of Ͼ0.2 mm was noted between the right and left eyes or in those eyes with small (р11.2 mm) or large (у12.2 mm) horizontal white-to-white measurement, the measurements were confi rmed with a caliper as the planned axis of implantation for the TICL was р15° from the horizontal meridian.
The internal OPD map from the OPD-Scan II (NIDEK Co Ltd, Gamagori, Japan) was used to assess the axis of induced internal astigmatism by TICL and hence assessed the axis alignment and the rotational stability. The internal OPD map is a color-coded, refractive wavefront map displaying the refractive power of the eye plotted in diopters after subtracting the refractive power of the anterior corneal surface (Fig  1) . To compensate for possible cylclorotation during examination, the axis of the steepest Sim K obtained from the axial map (at day 1) of the OPD-Scan II was used as a baseline to compensate for any cyclorotation during examination that would induce error. The OPD-Scan II examinations were considered valid only if obtained with a mesopic pupil size у6 mm. Phenylephrine hydrochloride 2.5% (2.5% Mydfrin; 
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Alcon Laboratories Inc, Ft Worth, Tex) eye drops were used to dilate the pupil if the desired pupil size was not obtained normally (one drop initially and examined 20 minutes later). Only 10 eyes of 5 patients required pharmacological pupil dilation. Examination at day 1 was considered the baseline for axis alignment. All eyes were examined at 1 and 3 months, at which time UCVA, BSCVA, axis alignment, and manifest refraction were measured.
SURGICAL TECHNIQUE
On the day of surgery, topical dilating and cycloplegic drops were instilled. All 35 eyes were implanted with a V4 model TICL under topical anesthesia. The horizontal axis was marked at the slit to account for cyclotorsion once the patient was supine. During surgery, the Mendez ring (Rhein Medical, Tampa, Fla) was used to mark the intended axis of alignment of the TICL. A 3-mm corneal incision was placed at the planned TICL axis to minimize intraocular rotation, followed by delivery of sodium hyaluronate 1% viscoelastic material (Healon; Abbott Medical Optics Inc, Santa Ana, Calif) into the anterior chamber. The TICL was injected slowly into the anterior chamber allowing for slow unfolding, and injection was not fi nished until the leading footplates were completely unfolded. The four footplates were inserted behind the iris using a modifi ed intraocular spatula by gentle posterior pressure combined with slight rotation, which was performed through the main wound for the proximal footplates and through a second incision for the distal footplates. If needed, adjustment of the implant was performed by gently manipulating the lens at the haptic-optic junction. The viscoelastic material was removed and the fi nal position of the lens was checked before an intraocular miotic was used to decrease pupil size. A peripheral iridectomy was performed using the vitrectomy mode of the INFINITI Vision System (Alcon Laboratories Inc) with 300-mmHg vacuum and 10-second cutting rate; the probe was introduced into the anterior chamber after viscoelastic injection at the desired iridectomy site. Following iridectomy, the viscoelastic material was washed using an irrigation/aspiration cannula, an antibiotic (vancomycin) was delivered intraocularly, and the wound was secured by stromal hydration.
RESULTS
Mean patient age was 26.49Ϯ6.52 years (range: 19 to 43 years). At 1 and 3 months postoperatively, 31 (88.6%) of 35 eyes were available for follow-up; the remaining 4 eyes were lost to follow-up. All eyes had preoperative myopia ranging from 1.00 to 16.00 D and preoperative cylinder ranging from 1.00 to 5.50 D. Baseline clinical characteristics are presented in Table 1 . Table 2 and Figure 2 present the manifest refraction cylinder before and 3 months after implantation of the TICL. Preoperatively, 8.6% (3/35) of eyes had р1.00 D refractive cylinder and 87.1% (27/31) of eyes had р1.00 D refractive cylinder at 3 months. No eyes had р0.50 D refractive cylinder preoperatively, 
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MANIFEST REFRACTION SPHERICAL EQUIVALENT
Mean manifest refraction spherical equivalent (MRSE) improved from Ϫ7.61Ϯ4.02 D to Ϫ0.14Ϯ0.38 D at 3 months. Preoperatively, no eyes had MRSE within 1.50 D of emmetropia; however, 96.8% (30/31) of eyes had MRSE within 1.50 D at 3 months postoperative. One eye had residual myopia of Ϫ1.25 D. In this eye, the TICL implanted was 1.00 D less than the lens that was required to achieve emmetropia due to the necessary manufacture time, which was not suitable for the patient's schedule; therefore, he consented to implantation of a TICL that would leave him partially myopic.
OPD-SCAN II ASSESSMENT OF AXIS MISALIGNMENT
The mean absolute value of the measured axis misalignment from the planned axis was 3.36Ϯ2.50°. The mean of the absolute value of measured axis misalignment from baseline to 1 month was 2.90Ϯ2.11° compared with 4.6Ϯ11.2° of misalignment from 1 to 3 months. When excluding the one eye with rotation at 3 months, the mean absolute value of axis misalignment between 1 and 3 months decreases to 2.64Ϯ2.4°. At 3 months, the mean absolute value of axis misalignment from baseline was 2.68Ϯ2.11° (after excluding the eye with rotation). At 3 months, 96.8% (30/31) of eyes had р8° and 90.3% (28/31) of eyes had р5° of axis misalignment (Fig 4) .
DISCUSSION
In our study, TICL implantation decreased refractive cylinder by 77.5%, which is supported by results of other studies reporting reductions of 70.1% 11 and 73.6%. 2 We found the majority of eyes (96.8%) had MRSE within 1.50 D of emmetropia. These results indicate the TICL was predictable at reducing astigmatism from 1.00 to 5.00 D.
One key factor in determining refractive outcome after TICL implantation is postoperative rotation. Rotation of the TICL was found to decrease the cylinder correction in a previous study. 12 Theoretical analysis 13, 14 and clinical results 15 have reported a steady loss of cylinder correction as the toric IOL rotates off-axis. In our study, we objectively measured the TICL axis alignment using the internal OPD map obtained, which is different from previous studies that measured axis alignment using slit-lamp digital camera 9 and slitlamp assessment. 11 Cyclotorsion was compensated for in this study by measuring the difference (between different examinations) in axis of the steepest corneal meridian displayed on the axial map of the OPD-Scan II, which was not addressed in the previously mentioned studies. 9, 11 For example, Park et al 9 measured axis misalignment from the intended axis at 6 months postoperatively, yet they did not assess the rotational TICL Axis Alignment and Rotational Stability/Hashem et al stability as the measured axis misalignment could either be due to TICL rotation or an incorrect alignment intraoperatively. The results of our study of axis misalignment at 3 months are supported by previous investigations. For example, we found mean absolute value of axis misalignment was 2.68Ϯ2.11° (excluding the one eye that rotated) in the current study compared with 2.20Ϯ5.50° reported by Sanders et al 11 and 1.30Ϯ5.15° reported by Park et al 9 ; the lower value of the standard deviation in the current study refl ects the more accurate measurements obtained by the OPDScan II compared with other previously used methods. One eye rotated signifi cantly by 66°, which required repositioning, and this eye regained MRSE within 0.50 D after repositioning.
The limitation of our study is the small number of eyes and short follow-up. We are currently completing a longer-term follow-up study, the results of which will be reported in the future.
